Growth Metrics

Forte Biosciences (FBRX) Profit After Tax (2016 - 2020)

Historic Profit After Tax for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$10.3 million.

  • Forte Biosciences' Profit After Tax rose 3982.67% to -$10.3 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$56.7 million, marking a year-over-year decrease of 668.37%. This contributed to the annual value of -$63.5 million for FY2019, which is 2974.36% down from last year.
  • As of Q1 2020, Forte Biosciences' Profit After Tax stood at -$10.3 million, which was up 3982.67% from -$10.6 million recorded in Q4 2019.
  • In the past 5 years, Forte Biosciences' Profit After Tax ranged from a high of -$383000.0 in Q3 2018 and a low of -$19.6 million during Q4 2018
  • Moreover, its 5-year median value for Profit After Tax was -$10.3 million (2020), whereas its average is -$11.5 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 9615.19% in 2018, then tumbled by 479164.49% in 2019.
  • Forte Biosciences' Profit After Tax (Quarter) stood at -$8.4 million in 2016, then decreased by 28.55% to -$10.8 million in 2017, then tumbled by 80.89% to -$19.6 million in 2018, then surged by 46.01% to -$10.6 million in 2019, then rose by 2.86% to -$10.3 million in 2020.
  • Its Profit After Tax stands at -$10.3 million for Q1 2020, versus -$10.6 million for Q4 2019 and -$18.7 million for Q3 2019.